Support for Individual Accounts

Welcome to IBKR Support

or Browse all FAQs

SYSTEM STATUS

Normal Operations

No problems reported at this time.

UPDATED: 2024/11/20 09:51:53

More Info

Getting Started:

Visit our Welcome Center for info on trading, managing, funding, and configuring your account, plus other key features.

Investor Grievance Escalation Matrix for IB India Accounts


You are requested to use the standard modes of communication (chats, calls or tickets through your secure Client Portal) to contact our client services team. In case you do not get a timely response or are not satisfied with the response provided, you can send an email as per the below escalation matrix mentioning your ticket number. Please do not use the escalation matrix as the first line of communication.

Details of Contact Person Address Contact Number Email Address
Customer Care Rinku Chauhan 502/A, Times Square, Andheri Kurla Road, Andheri East, Mumbai 400059, India +91-22-61289888
(Mon-Fri ; 10 am to 5 pm)
customercareescalation.in@interactivebrokers.com
Head of Customer Care/Board Member Praveen Kamath +91-22-39696188
(Mon-Fri ; 10 am to 5 pm)
customercareheadescalation.in@interactivebrokers.com
Compliance Officer Bina Shah +91-22-61289825
(Mon-Fri ; 10 am to 5 pm)
complianceofficerescalation.in@interactivebrokers.com

In Absence of response/complaint not addressed to your satisfaction, you may lodge a complaint with Exchange at https://investorhelpline.nseindia.com/NICEPLUS/ or NSDL at https://www.epass.nsdl.com/complaints/websitecomplaints.aspx or SEBI at https://scores.sebi.gov.in. Further, you can also raise a complaint/dispute via the Online Dispute Resolution (ODR) portal http://smartodr.in. Please quote your Service Ticket/Complaint Ref No. while raising your complaint at Exchange/Depository/SEBI SCORES/ODR Portal.

NSDL IDeAS

Bank Account Details

Key Managerial Personnel

The NSE cautions and advises investors not to subscribe to any prohibited scheme or products. Participation in such prohibited schemes is at investors' own risk, as such schemes are neither approved nor endorsed by the Exchange. Further details on the NSE Press releases can be found on the their website HERE.